Activation of RyR2 by class I kinase inhibitors.
Chakraborty AD, Gonano LA, Munro ML, Smith LJ, Thekkedam C, Staudacher V, Gamble AB, Macquaide N, Dulhunty AF, Jones PP.
Chakraborty AD, et al. Among authors: gamble ab.
Br J Pharmacol. 2019 Mar;176(6):773-786. doi: 10.1111/bph.14562. Epub 2019 Jan 30.
Br J Pharmacol. 2019.
PMID: 30588601
Free PMC article.